• Explore /
  • Poster
  • / Atezolizumab and trastuzumab plus chemotherapy in patients with HER2+ locally advanced resectable gastric cancer or adenocarcinoma of the gastroesophageal junction: A multicenter, randomized, open-label phase II study.

Atezolizumab and trastuzumab plus chemotherapy in patients with HER2+ locally advanced resectable gastric cancer or adenocarcinoma of the gastroesophageal junction: A multicenter, randomized, open-label phase II study.

Abstract Poster

Authors

null

Zhi Peng

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Oncology, Peking University Cancer Hospital and Institute, HaiDian District, Beijing, Beijing, China

Zhi Peng , Xiaotian Zhang , Han Liang , Zhichao Zheng , Zhenning Wang , Hao Liu , Jiankun Hu , Yihong Sun , Yanqiao Zhang , Han Yan , Lin Tong , Jiahui Xu , Jessica Xie , Jiafu Ji , Lin Shen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04661150

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 312)

DOI

10.1200/JCO.2024.42.3_suppl.312

Abstract #

312

Poster Bd #

E12

Abstract Disclosures

Similar Posters

First Author: Kohei Shitara

First Author: Jin Li

First Author: Yelena Y. Janjigian

First Author: Lin Shen